Rights and permissions
About this article
Cite this article
Bortezomib phase II clinical trial: further accrual stopped. Inpharma Wkly. 1420, 8 (2004). https://doi.org/10.2165/00128413-200414200-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414200-00016